SE468074B - Preparat foer foerbaettring av den cellulaera metabolismen - Google Patents

Preparat foer foerbaettring av den cellulaera metabolismen

Info

Publication number
SE468074B
SE468074B SE8505527A SE8505527A SE468074B SE 468074 B SE468074 B SE 468074B SE 8505527 A SE8505527 A SE 8505527A SE 8505527 A SE8505527 A SE 8505527A SE 468074 B SE468074 B SE 468074B
Authority
SE
Sweden
Prior art keywords
mmol
potassium
preparation according
preparation
phosphate
Prior art date
Application number
SE8505527A
Other languages
English (en)
Swedish (sv)
Other versions
SE8505527L (sv
SE8505527D0 (sv
Inventor
N C Henningsen
Original Assignee
Medina Hb
Nels Christian Pragholm Hennin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medina Hb, Nels Christian Pragholm Hennin filed Critical Medina Hb
Priority to SE8505527A priority Critical patent/SE468074B/sv
Publication of SE8505527D0 publication Critical patent/SE8505527D0/xx
Priority to AU65133/86A priority patent/AU592385B2/en
Priority to DE8686850396T priority patent/DE3684882D1/de
Priority to AT86850396T priority patent/ATE74760T1/de
Priority to JP61273068A priority patent/JPH07100660B2/ja
Priority to EP86850396A priority patent/EP0223762B1/fr
Priority to DE198686850396T priority patent/DE223762T1/de
Priority to CA000523514A priority patent/CA1275927C/fr
Priority to DK560286A priority patent/DK164200C/da
Priority to FI864749A priority patent/FI864749A/fi
Priority to NO864682A priority patent/NO175845C/no
Publication of SE8505527L publication Critical patent/SE8505527L/
Publication of SE468074B publication Critical patent/SE468074B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Special Wing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
SE8505527A 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen SE468074B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8505527A SE468074B (sv) 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen
AU65133/86A AU592385B2 (en) 1985-11-22 1986-11-14 Composition to improve cellular metabolism
DE198686850396T DE223762T1 (de) 1985-11-22 1986-11-18 Zusammensetzung fuer den zellstoffwechsel.
JP61273068A JPH07100660B2 (ja) 1985-11-22 1986-11-18 細胞代謝を向上させる組成物
AT86850396T ATE74760T1 (de) 1985-11-22 1986-11-18 Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels.
DE8686850396T DE3684882D1 (de) 1985-11-22 1986-11-18 Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels.
EP86850396A EP0223762B1 (fr) 1985-11-22 1986-11-18 Utilisation d'une composition pour l'obtention d'un médicament pour améliorer le métabolisme cellulaire
CA000523514A CA1275927C (fr) 1985-11-22 1986-11-21 Composition destinee a ameliorer le metabolisme cellulaire
DK560286A DK164200C (da) 1985-11-22 1986-11-21 Praeparat til forbedring af den cellulaere metabolisme
FI864749A FI864749A (fi) 1985-11-22 1986-11-21 Preparat foer foerbaettring av den cellulaera metabolismen.
NO864682A NO175845C (no) 1985-11-22 1986-11-21 Anvendelse av kalium-, magnesium- og fosfationer i slankepreparat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505527A SE468074B (sv) 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen

Publications (3)

Publication Number Publication Date
SE8505527D0 SE8505527D0 (sv) 1985-11-22
SE8505527L SE8505527L (sv) 1987-05-23
SE468074B true SE468074B (sv) 1992-11-02

Family

ID=20362216

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8505527A SE468074B (sv) 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen

Country Status (10)

Country Link
EP (1) EP0223762B1 (fr)
JP (1) JPH07100660B2 (fr)
AT (1) ATE74760T1 (fr)
AU (1) AU592385B2 (fr)
CA (1) CA1275927C (fr)
DE (2) DE3684882D1 (fr)
DK (1) DK164200C (fr)
FI (1) FI864749A (fr)
NO (1) NO175845C (fr)
SE (1) SE468074B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207800B (en) * 1990-05-10 1993-06-28 Andras Sikter Process for producing composition for improving condition and for treating different illnesses
US5639471A (en) * 1995-06-06 1997-06-17 Campbell Soup Company Method for determining diet program effectiveness
DE19925483A1 (de) * 1998-06-04 2000-02-03 Ludwig Schwebel Wirkstoff zur Behandlung der Zuckerkrankheit
GB9819530D0 (en) 1998-09-09 1998-10-28 Smithkline Beecham Plc Novel compositions and use
US9585827B2 (en) * 2000-01-21 2017-03-07 The Procter & Gamble Company Kits comprising a beverage composition and information for use
CN102949413B (zh) * 2012-06-08 2014-12-03 辽宁海思科制药有限公司 一种转化糖电解质注射液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1796976A (en) * 1975-09-23 1978-04-06 Johnson & Johnson Electrolyte mixtures and drinks
US4322407A (en) * 1978-12-11 1982-03-30 Vitapharm Pharmaceutical Pty. Ltd. Electrolyte drink

Also Published As

Publication number Publication date
SE8505527L (sv) 1987-05-23
AU6513386A (en) 1987-05-28
FI864749A0 (fi) 1986-11-21
SE8505527D0 (sv) 1985-11-22
CA1275927C (fr) 1990-11-06
NO864682L (no) 1987-05-25
DE3684882D1 (de) 1992-05-21
FI864749A (fi) 1987-05-23
DK560286A (da) 1987-05-23
NO175845B (fr) 1994-09-12
EP0223762B1 (fr) 1992-04-15
EP0223762A1 (fr) 1987-05-27
AU592385B2 (en) 1990-01-11
NO864682D0 (no) 1986-11-21
JPH07100660B2 (ja) 1995-11-01
NO175845C (no) 1994-12-21
ATE74760T1 (de) 1992-05-15
DK164200B (da) 1992-05-25
DK560286D0 (da) 1986-11-21
JPS62171654A (ja) 1987-07-28
DK164200C (da) 1992-10-19
DE223762T1 (de) 1987-10-15

Similar Documents

Publication Publication Date Title
Manore Exercise and the Institute of Medicine recommendations for nutrition
Burke et al. Effect of coingestion of fat and protein with carbohydrate feedings on muscle glycogen storage
Felig Insulin is the mediator of feecling‐related thermogenesis: insulin resistance and/or deficiency results in a thermogenic defect which contributes to the pathogenesis of obesity
JP2593882B2 (ja) エネルギー補給用スポーツ飲料
Young et al. Effect of oral sucrose on blood pressure in the spontaneously hypertensive rat
AU685882B2 (en) New beverage
Gleeson et al. The effects of physical exercise on metabolic rate and dietary-induced thermogenesis
Venter et al. Comparison between physiological effects of konjac-glucomannan and propionate in baboons fed “Western” diets
PL190526B1 (pl) Leczniczo-odżywczy preparat dla osób chorych na cukrzycę
Landsberg Obesity and hypertension: experimental data
Paul et al. Amino acid and protein metabolism during exercise and recovery
Harris Feeding management of elite endurance horses
SE468074B (sv) Preparat foer foerbaettring av den cellulaera metabolismen
Martin et al. The regulation of body weight
MAYNARD Exercise: Part I. Physiological response to exercise in diabetes mellitus
Stanley et al. The effect of dietary guar gum on the activities of some key enzymes of carbohydrate and lipid metabolism in mouse liver
Ireton‐Jones et al. Invited Review: Nutrition for Adult Burn Patients: A Review
Taylor et al. Daily protein and meal patterns affecting young men fed adequate and restricted energy intakes
Kahle et al. Exercise adaptation responses for gastric inhibitory polypeptide (GIP) and insulin in obese children: possible extra-pancreatic effects
Rutten Adverse effects of nutrients
Martin et al. Glucose metabolism during physical exercise in patients with noninsulin-dependent (type II) diabetes
Fleming et al. Fluctuations in plasma pyrroline-5-carboxylate concentrations during feeding and fasting
Koutedakis Nutrition to fuel dance: A brief review
Lawrence The Action of Insulin in Glycogen Formation and Its Therapeutic Application
Jensen et al. The diabetic athlete

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8505527-5